Reversible skeletal neuromuscular paralysis induced by different lysophospholipids

FEBS Letters

Volumn 580, Issue 27, 2006, Pages 6317-6321

  Caccin, Paola ^a   Rigoni, Michela ^a   Bisceglie, Alessandra ^a   Rossetto, Ornella ^a   Montecucco, Cesare ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Lysophospholipids; Neuromuscular junction; Paralysis; Phospholipase A2; Snake neurotoxins

Indexed keywords

ALBUMIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLETHANOLAMINE; LYSOPHOSPHATIDYLGLYCEROL; LYSOPHOSPHATIDYLSERINE; LYSOPHOSPHOLIPID; MAGNESIUM ION; NEUROTOXIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXOCYTOSIS; KINETICS; MOUSE; NEUROMUSCULAR SYNAPSE; NEUROTOXICITY; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; SNAKE;

ALBUMINS; ANIMALS; DIAPHRAGM; EXOCYTOSIS; LYSOPHOSPHOLIPIDS; MAGNESIUM; MICE; NEUROMUSCULAR JUNCTION; NEUROTOXINS; ORGAN CULTURE TECHNIQUES; PARALYSIS; PHOSPHOLIPASES A; PHRENIC NERVE; SNAKE VENOMS;

EID: 33751020820     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.10.039     Document Type: Article

References (25)

1. Dixon R.W., and Harris J.B. Nerve terminal damage by beta-bungarotoxin: its clinical significance. Am. J. Pathol. 154 (1999) 447-455
2. Kini, R.M. (1997) Venom phospholipase A2 enzymes. Structure, function and mechanism. Wiley and Sons, Eds., Chichester.
3. Montecucco C., and Rossetto O. How do presynaptic PLA2 neurotoxins block nerve terminals?. Trends Biochem. Sci. 25 (2000) 266-270
4. Rossetto O., Morbiato L., Caccin P., Rigoni M., and Montecucco C. Presynaptic enzymatic neurotoxins. J. Neurochem. 97 (2006) 1534-1545
5. Rowan E.G. What does β-bungarotoxin do at the neuromuscular junction?. Toxicon 39 (2001) 107-118
6. Harris J.B. Toxic phospholipases in snake venom: an introductory review. Symp. Zool. Soc. Lond. 70 (1997) 235-250
7. Howard B.D., and Gundersen Jr. C.B. Effects and mechanisms of polypeptide neurotoxins that act presynaptically. Annu. Rev. Pharmacol. Toxicol. 20 (1980) 307-336
8. Kelly R.B., Oberg S.G., Strong P.N., and Wagner G.M. β-Bungarotoxin, a phospholipase that stimulates transmitter release. Cold Spring Harb. Symp. Quant. Biol. 40 (1976) 117-125
9. Chen I.L., and Lee C.Y. Ultrastructural changes in the motor nerve terminals caused by beta-bungarotoxin. Virchows Arch. B Cell Pathol. 6 (1970) 318-325
10. Cull-Candy S.G., Fohlman J., Gustavsson D., Lullmann-Rauch R., and Thesleff S. The effects of taipoxin and notexin on the function and fine structure of the murine neuromuscular junction. Neuroscience 1 (1976) 175-180
11. Gopalakrishnakone P., and Hawgood B.J. Morphological changes induced by crotoxin in murine nerve and neuromuscular junction. Toxicon 22 (1984) 791-804
12. Harris J.B., Grubb B.D., Maltin C.A., and Dixon R. The neurotoxicity of the venom phospholipases A(2), notexin and taipoxin. Exp. Neurol. 161 (2000) 517-526
13. Lee C.Y., Tsai M.C., Chen Y.M., Ritonja A., and Gubensek F. Mode of neuromuscular blocking action of toxic phospholipases A2 from Vipera ammodytes venom. Arch. Int. Pharmacodyn. Ther. 268 (1984) 313-324
14. Bonanomi D., Pennuto M., Rigoni M., Rossetto O., Montecucco C., and Valtorta F. Taipoxin induces synaptic vesicle exocytosis and disrupts the interaction of synaptophysin I with VAMP2. Mol. Pharmacol. 67 (2005) 1901-1908
15. Rigoni M., Schiavo G., Weston A.E., Caccin P., Allegrini F., Pennuto M., Valtorta F., Montecucco C., and Rossetto O. Snake presynaptic neurotoxins with phospholipase A2 activity induce punctate swellings of neurites and exocytosis of synaptic vesicles. J. Cell Sci. 117 (2004) 3561-3570
16. Rigoni M., Caccin P., Gschmeissner S., Koster G., Postle A.D., Rossetto O., Schiavo G., and Montecucco C. Equivalent effects of snake PLA2 neurotoxins and lysophospholipid-fatty acid mixtures. Science 310 (2005) 1678-1680
17. Chernomordik L.V., and Kozlov M.M. Protein-lipid interplay in fusion and fission of biological membranes. Annu. Rev. Biochem. 72 (2003) 175-207
18. Zimmerberg J., and Chernomordik L.V. Neuroscience. Synaptic membranes bend to the will of a neurotoxin. Science 310 (2005) 1626-1627
19. Reynolds L.J., Hughes L.L., and Dennis E.A. Analysis of human synovial fluid phospholipase A2 on short chain phosphatidylcholine-mixed micelles: development of a spectrophotometric assay suitable for a microtiterplate reader. Anal. Biochem. 204 (1992) 190-197
20. Bulbring E. Observations on the isolated phrenic nerve diaphragm preparation of the rat. Brit. J. Pharmacol. 1 (1946) 38-61
21. Simard J.R., Zunszain P.A., Hamilton J.A., and Curry S. Location of high and low affinity fatty acid binding sites on human serum albumin Revealed by NMR drug-competition analysis. J. Mol. Biol. 361 (2006) 336-351
22. Curry S., Mandelkow H., Brick P., and Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Biol. 5 (1998) 827-835
23. Melia T.J., You D., Tareste D.C., and Rothman J.E. Lipidic antagonists to SNARE-mediated fusion. J. Biol. Chem. (2006)
24. Kamenskaya M.A., and Thesleff S. The neuromuscular blocking action of an isolated toxin from the elapid (Oxyuranus scutellactus). Acta Physiol. Scand. 90 (1974) 716-724
25. Simpson L.L., Lautenslager G.T., Kaiser I.I., and Middlebrook J.L. Identification of the site at which phospholipase A2 neurotoxins localize to produce their neuromuscular blocking effects. Toxicon 31 (1993) 13-26